No Data
No Data
Zhejiang Garden Biopharmaceutical (300401.SZ): The company's market share of Vitamin D3 products currently stands at 30-40%.
On April 7th, Gelonghui reported that Zhejiang Garden Biopharmaceutical (300401.SZ) recently stated in an investor relations activity that the current market share of its Vitamins D3 products is 30-40%.
Express News | Zhejiang Garden Biopharmaceutical: The vast majority of products exported to the USA are not subject to tariff increases, and price hikes cannot be ruled out.
Express News | Zhejiang Garden Biopharmaceutical: The impact of tariffs on the company is limited.
Zhejiang Garden Biopharmaceutical (300401): Performance improves, actively expanding new Business.
Core viewpoint: performance has reached an inflection point, and profit improvement is significant. The company released its 2024 annual report, achieving revenue of 1.243 billion yuan (up 13.58% year-on-year), with a net income of 0.309 billion yuan (up 60.76% year-on-year).
Garden Creatures: 2024 Annual Report
Garden Creatures: 2024 Annual Report Summary